EU Psoriatic Arthritis Treatment Market, Market Segmented by Drug Class (Non-steroidal Anti-inflammatory Drugs (NSAIDS), Non-biologic Disease Modifying Anti-Rheumatic Drugs (DMARDs), Biologic Disease Modifying Anti-Rheumatic Drugs (DMARDs) and Others), by Route of Administration (Oral, Parenteral, Injectable and Topical) and by Distribution Channel (Hospital Pharmacies, Retail Pharmacies and Online Pharmacies) Growth, Trends and Forecast, 2019-2028
- Published Date: 2022-12-26
- Report ID: 138215
- Pages: 200
-
Format:
Report Overview
The EU Psoriatic Arthritis Treatment market size stood at around USD xx billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period
Psoriatic arthritis is a chronic degenerative condition associated with psoriasis. In the absence of proper and timely treatment, the disease may lead to irreversible joint damage. Although the exact causative factors remain unknown, research suggests that nearly 40% of cases are attributable to genetic factors
Market Drivers
The consumer demand for cost-effective medicines with improved safety and efficacy profiles is likely to have a positive impact on market dynamics. The promising pipeline, new product launches, increasing disease burden, and a significant rise in consumer awareness are some of the factors expected to fuel the growth
1. EU Psoriatic Arthritis Treatment Market Overview.......................
A. Market Size
2. EU Psoriatic Arthritis Treatment Growth Drivers.................
A. Rise in Customer Awareness and Increase Disease Burden
B. Promising Pipeline and New Product Launches
3. EU Psoriatic Arthritis Treatment Market Segmentation.
A. By Drug Class
I. Non-steroidal Anti-inflammatory Drugs (NSAIDS)
II. Non-biologic Disease Modifying Anti-Rheumatic Drugs (DMARDs)
III. Biologic Disease Modifying Anti-Rheumatic Drugs (DMARDs)
IV. Others
B. By Route of Administration
I. Oral
II. Parenteral
III. Topical
IV. Injectable
C. By Distribution Channel
I. Hospitals Pharmacies
II. Retail Pharmacies
III. Online Pharmacies
4. EU Psoriatic Arthritis Treatment Major Market Share...................
A. Market Analysis, Insights and Forecast by Revenue
5. Competitive Landscape
A. Major Players
B. Products in Pipeline
6. Key Company Profiles..
A Novartis AG Company overview, Product & Services, Strategies & Financials
B Glaxo Smith Kline Company overview, Product & Services, Strategies & Financials
C Astra Zeneca Company overview, Product & Services, Strategies & Financials
7. Healthcare Policies and Regulatory Landscape.
A. Policy Changes and Reimbursement Scenario
8. Factors Driving Market Growth
A. Key Industry Developments
B. Mergers and Acquisitions
9. Potential Growth Opportunities
A. Market Opportunities
B. Future Trends
10. Conclusion
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
